Tag Archives: patent cliff

Spending Rises on Prescription Drugs, Despite Overall Slowdown in Healthcare Outlays

More new medicines came to market in 2013, and fewer blockbuster drugs lost patent protection, trends that federal analysts say led to more rapid growth in outlays for prescription drugs in 2013. Retail prescription drug spending rose 2.5% to reach $271 billion a year ago, much faster than the low growth rate of 0.5% in […]
Posted in drug spending, healthcare, IP, pricing | Also tagged , | 1 Comment

Pharma Showing Signs of Stability Despite Patent Cliffs

The pharmaceutical market is beginning to show signs of stability, with a review of 30 leading companies highlighting combined revenues of $718.7 billion in 2013, down just 0.2% from 2012, according to GlobalData.
Posted in Deals, Strategy | Also tagged , , , , , | Leave a comment

Is the Worst of the Patent Cliff Behind Us?

By Amy Ritter. In a bit of good news for pharma, Moody’s Investors Service has upgraded its outlook for the global pharmaceutical industry to stable. The Moody’s rating reflects expectations for fundamental business conditions in the industry over the next 12 to 18 months, and until now, the industry had been limping along under a […]
Posted in Op-Ed | Also tagged , , | 1 Comment
  • Categories

  • Meta